The manufacturer of a generic version of the abortion drug mifepristone sued the Food and Drug Administration on Wednesday to prevent any new restrictions on the pill.
Subscribe to:
Post Comments (Atom)
< + > Building the Healthcare AI Infrastructure Needed for the Next Era of Care
In a recent video interview with Healthcare IT Today, experts from two healthcare technology companies focus on the latest happenings with h...
No comments:
Post a Comment